Aristo Bio-tech An
NSE: ARISTO-SM
NSE
130.15
0.00 (0.00%)
Prev Close
130.15
Open Price
130.2
Volume
3,200
Today Low / High
130.15 / 130.2
52 WK Low / High
130.15 / 130.2
Range
124 - 137
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 130.15, with a change of 0 (0%). The expected target range on the NSE is between 124 - 137. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
Aristo Bio-tech An Graph
Aristo Bio-tech An Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aristo Bio-tech An T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 130.15, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 130.15 | 131.45 | 118.31 - 144.60 |
| 132.75 | 106.20 - 159.30 | ||
| 134.05 | 93.84 - 174.27 | ||
| Bearish Scenario | 130.15 | 128.85 | 115.96 - 141.73 |
| 127.55 | 102.04 - 153.06 | ||
| 126.25 | 88.37 - 164.12 |
Overview of Aristo Bio-tech An
ISIN
Industry
Chemicals
Vol.Avg
23,662
Market Cap
0
Last Dividend
0
Official Website
IPO Date
DCF Diff
208.59
DCF
-49
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 245.15 Cr | 226.04 Cr | 19.11 Cr | 0.0780 | 0.00 Cr | 3.70 Cr | 15.38 Cr | 3.90 Cr | 5.72 | 8.56 Cr | 0.0159 |
| 2023-03-31 | 217.86 Cr | 196.00 Cr | 21.86 Cr | 0.1003 | 0.00 Cr | 5.82 Cr | 7.26 Cr | 3.56 Cr | 6.72 | 8.79 Cr | 0.0164 |
| 2022-03-31 | 165.76 Cr | 147.20 Cr | 18.56 Cr | 0.1120 | 0.00 Cr | 5.39 Cr | 4.13 Cr | 1.43 Cr | 2.87 | 5.23 Cr | 0.0086 |
| 2021-03-31 | 167.22 Cr | 150.15 Cr | 17.07 Cr | 0.1021 | 0.00 Cr | 3.63 Cr | 3.59 Cr | 1.08 Cr | 2.15 | 4.34 Cr | 0.0064 |
| 2020-03-31 | 201.23 Cr | 187.66 Cr | 13.58 Cr | 0.0675 | 0.00 Cr | 3.84 Cr | 3.99 Cr | 1.01 Cr | 2.02 | 4.51 Cr | 0.0050 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 5.41 Cr | 127.29 Cr | 93.68 Cr | 33.6086 Cr | 20.88 Cr | 15.46 Cr | 40.19 Cr | 21.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 83.5682 Cr |
| 2023-03-31 | 3.80 Cr | 99.83 Cr | 69.67 Cr | 30.1554 Cr | 22.49 Cr | 18.69 Cr | 30.78 Cr | 16.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 59.4856 Cr |
| 2022-03-31 | 2.60 Cr | 77.00 Cr | 62.14 Cr | 14.8657 Cr | 25.48 Cr | 22.88 Cr | 24.36 Cr | 14.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 50.9393 Cr |
| 2021-03-31 | 0.11 Cr | 81.42 Cr | 68.04 Cr | 13.3808 Cr | 22.25 Cr | 22.14 Cr | 31.95 Cr | 12.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 55.9727 Cr |
| 2020-03-31 | 0.53 Cr | 87.85 Cr | 75.55 Cr | 12.3051 Cr | 19.71 Cr | 19.18 Cr | 24.32 Cr | 11.07 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 64.8752 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 7.6004 Cr | -6.6096 Cr | -2.2066 Cr | 1.0455 Cr | -1.2158 Cr | 0.6371 Cr | -6.5549 Cr | 3.8957 Cr | -0.1696 Cr | -0.4425 Cr | -9.4095 Cr |
| 2023-03-31 | -2.7836 Cr | -3.7456 Cr | 7.9657 Cr | -6.8441 Cr | 1.4365 Cr | 1.8529 Cr | -4.0605 Cr | 3.5622 Cr | -0.9251 Cr | 0.0000 Cr | -6.4152 Cr |
| 2022-03-31 | 6.7781 Cr | -3.1601 Cr | -3.3138 Cr | 3.5293 Cr | 0.3041 Cr | 0.4164 Cr | -3.2488 Cr | 1.4338 Cr | -0.9689 Cr | 0.0000 Cr | 7.5833 Cr |
| 2021-03-31 | 2.2841 Cr | -1.9778 Cr | -0.7191 Cr | 0.2948 Cr | -0.4128 Cr | 0.1123 Cr | -1.9893 Cr | 1.0757 Cr | 1.3891 Cr | 0.0000 Cr | -7.6214 Cr |
| 2020-03-31 | 1.4070 Cr | -2.1923 Cr | 0.8725 Cr | -0.7933 Cr | 0.0872 Cr | 0.5251 Cr | -2.2003 Cr | 1.0074 Cr | 3.4731 Cr | 0.0000 Cr | 8.6638 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 56.16 Cr | 52.07 Cr | 4.09 Cr | 0.0728 | 4.01 Cr | 0.66 Cr | 0.97 | 1.66 Cr | 0.0118 |
| 2023-12-31 | 56.16 Cr | 51.91 Cr | 4.25 Cr | 0.0757 | 1.23 Cr | 0.66 Cr | 0.97 | 1.62 Cr | 0.0118 |
| 2023-09-30 | 66.41 Cr | 60.95 Cr | 5.46 Cr | 0.0823 | 2.23 Cr | 1.29 Cr | 1.89 | 2.62 Cr | 0.0194 |
| 2023-06-30 | 66.41 Cr | 60.95 Cr | 5.46 Cr | 0.0823 | 2.23 Cr | 1.29 Cr | 1.89 | 2.62 Cr | 0.0194 |
| 2023-03-31 | 44.39 Cr | 39.50 Cr | 4.89 Cr | 0.1103 | 1.44 Cr | 0.49 Cr | 0.87 | 1.85 Cr | 0.0110 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 5.41 Cr | 0.00 Cr | 5.41 Cr | 57.47 Cr | 40.19 Cr | 105.03 Cr | 21.68 Cr | 127.29 Cr | 93.68 Cr |
| 2023-12-31 | 0.64 Cr | 0.00 Cr | 0.64 Cr | 57.47 Cr | 40.19 Cr | 105.03 Cr | 21.68 Cr | 127.29 Cr | 93.68 Cr |
| 2023-09-30 | 0.73 Cr | 0.00 Cr | 0.73 Cr | 75.31 Cr | 29.59 Cr | 109.91 Cr | 18.53 Cr | 128.44 Cr | 95.88 Cr |
| 2023-06-30 | 0.73 Cr | 0.00 Cr | 0.73 Cr | 75.31 Cr | 29.59 Cr | 109.91 Cr | 18.53 Cr | 128.44 Cr | 95.88 Cr |
| 2023-03-31 | 3.80 Cr | 0.00 Cr | 3.80 Cr | 44.57 Cr | 30.78 Cr | 83.10 Cr | 16.72 Cr | 99.83 Cr | 69.67 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 0.66 Cr | 2.26 Cr | -2.03 Cr | -0.28 Cr | -0.05 Cr | -0.05 Cr | 0.00 Cr | -1.98 Cr | 0.28 Cr |
| 2023-12-31 | 0.66 Cr | 2.26 Cr | -2.03 Cr | -0.28 Cr | -0.05 Cr | -0.05 Cr | 0.00 Cr | -1.98 Cr | 0.28 Cr |
| 2023-09-30 | 1.29 Cr | 1.54 Cr | -1.28 Cr | -0.82 Cr | -0.56 Cr | -0.56 Cr | 0.00 Cr | -1.29 Cr | 0.24 Cr |
| 2023-06-30 | 1.29 Cr | 1.54 Cr | -1.28 Cr | -0.82 Cr | -0.56 Cr | -0.56 Cr | 0.00 Cr | -1.29 Cr | 0.24 Cr |
| 2023-03-31 | 0.49 Cr | -2.78 Cr | -0.81 Cr | 3.86 Cr | 0.27 Cr | 0.27 Cr | 0.00 Cr | -0.91 Cr | -3.70 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Chemicals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Gujarat Fluorochemicals Limited | FLUOROCHEM | ₹3,520.80 | ₹386,759,880,000.00 | ₹48,689.00 |
| Deepak Nitrite Limited | DEEPAKNTR | ₹1,971.10 | ₹268,844,242,300.00 | ₹199,096.00 |
| Navin Fluorine International Limited | NAVINFLUOR | ₹4,875.50 | ₹241,777,507,650.00 | ₹77,774.00 |
| Tata Chemicals Limited | TATACHEM | ₹945.00 | ₹240,744,420,000.00 | ₹1,202,059.00 |
| Deepak Fertilisers And Petrochemicals Corporation Limited | DEEPAKFERT | ₹1,728.90 | ₹218,252,878,200.00 | ₹452,277.00 |
| Supreme Petrochem Limited | SPLPETRO | ₹837.25 | ₹157,437,327,250.00 | ₹29,905.00 |
| Gujarat Narmada Valley Fertilizers & Chemicals Limited | GNFC | ₹558.80 | ₹82,110,630,800.00 | ₹385,848.00 |
| Epigral Limited | EPIGRAL | ₹1,822.40 | ₹78,620,778,016.00 | ₹18,088.00 |
| Archean Chemical Industries Limited | ACI | ₹625.95 | ₹77,259,556,296.00 | ₹123,361.00 |
| Chemplast Sanmar Limited | CHEMPLASTS | ₹427.55 | ₹67,599,746,654.00 | ₹34,403.00 |
| India Glycols Limited | INDIAGLYCO | ₹2,080.10 | ₹64,403,016,150.00 | ₹58,720.00 |
| GHCL Limited | GHCL | ₹618.10 | ₹59,382,165,010.00 | ₹100,134.00 |
| Rain Industries Limited | RAIN | ₹150.67 | ₹50,677,251,820.00 | ₹2,673,579.00 |
| Meghmani Finechem Limited | MFL | ₹1,062.00 | ₹44,126,312,400.00 | ₹146,962.00 |
| Gujarat Alkalies and Chemicals Limited | GUJALKALI | ₹589.30 | ₹43,276,365,170.00 | ₹42,584.00 |
| Meghmani Organics Limited | MEGH | ₹139.00 | ₹35,285,704,610.00 | ₹5,511,910.00 |
| Foseco India Limited | FOSECOIND | ₹5,003.40 | ₹31,954,013,964.00 | ₹2,715.00 |
| Bhansali Engineering Polymers Limited | BEPL | ₹114.99 | ₹28,616,181,420.00 | ₹204,683.00 |
Key Executives
No executive data available.
FAQs about Aristo Bio-tech An
What is the current market price of the stock?
The current price is ₹130.15.
What is the 52-week price range?
The range is ₹130.15-130.2.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 67.08.
Which sector does the company belong to?
The company operates in the Basic Materials sector.